IFNG and neoplasm: Several studies identified high tumor mutational burden (TMB)8, T-cell infiltration9, PD-1 expression, programmed death-ligand 1 (PD-L1) expression10 and interferon-gamma (IFN-γ) signature expression11 at baseline (pre-immunotherapy) as potential predictors of response to immunotherapy.